Results 101 to 110 of about 126,252 (309)

Does Inflation Targeting Matter? A Reassessment [PDF]

This paper uses a number of identification approaches (using instrumental variables, assumptions about heteroscedasticity and panel fixed effects) to estimate the effect of inflation targeting on inflation.
Luke B. Willard
core  

Toward Saving Nozick from Kripke [PDF]

, 2003
Tracking theories of knowledge, though quite popular have been under attack from their inception. Specifically, we have in mind the attacks of Saul Kripke. We don"t think these attacks on tracking theories work.
Adams, Fred
core  

Cost Utility Analysis of Fluticasone Exhalation Delivery System Versus Budesonide Nasal Irrigation for Chronic Rhinosinusitis With Nasal Polyps

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is managed after sinus surgery with topical corticosteroids. Given limited distribution of nasal steroid sprays, patients have the option of either steroid nasal irrigation (SNI) or exhalation delivery system with fluticasone (EDS‐FLU).
Daniel Xiao, Martin J. Citardi, William C. Yao, Amber U. Luong   +3 more
wiley   +1 more source

Review for "High‐resolution, relational, resonance‐based, electroencephalic mirroring (HIRREM) improves symptoms and autonomic function for insomnia: A randomized, placebo‐controlled clinical trial"

, 2020

openalex   +1 more source

Dose response, efficacy and safety of the endothelina receptor antagonist LU 135252 compared with placebo in patients with moderate hypertension. The HEAT study: ?ypertension, ?ndothelin ?ntagonist ?reatment [PDF]

, 2001
Radislav Nakov
openalex   +1 more source

Dosing Interval Extension of Dupilumab in CRSwNP: Five‐Year Real World Outcomes

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is a persistent, often Type 2‐mediated inflammatory disease that markedly impairs quality of life. While dupilumab provides rapid improvement, there is limited evidence on long‐term outcomes beyond 2 years, and the clinical impact of dosing‐interval extension remains unclear.
Nicholas J. Campion, Dioni‐Pinelopi Petsiou, Florian C. Fally, Karina Berbalk, Noah F. Melamed, Aldine Tu, Christina Morgenstern, Fana Alem Kidane, Mohammed Zghaebi, Linda Liu, Minghao Pan, Tina J. Bartosik, Victoria Stanek, Katarina Gangl, Julia Eckl‐Dorna, Sven Schneider   +15 more
wiley   +1 more source

Supplementary Material for: Oxytocin Enhancement of the Placebo Effect May Be a Novel Therapy for Working Memory Impairments

, 2018
Weidong Zhao, Benjamin Becker, Sheng Yao, Xiao Ma, Junping Kou, Keith M. Kendrick   +5 more
openalex   +1 more source

Randomized placebo-controlled cross-over designs in clinical trials: a gold standard to be reassessed [PDF]

, 2011
Guillaume Léonard, Sylvie Lafrenaye, Philippe Goffaux   +2 more
openalex   +1 more source

Effect of Laser Posterior Nasal Neurolysis for the Treatment of Chronic Rhinitis: A Randomized Controlled Trial

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background To determine the safety and efficacy of laser ablation of the posterior nasal nerve (PNN) for the treatment of chronic rhinitis. Methods This study was a single‐center, prospective, single‐blinded, randomized sham‐controlled trial. Patients with a 24‐h reflective Total Nasal Symptom Score (rTNSS) ≧ 5, rhinorrhea ≧ 2, and congestion ≧
Jyun‐Yi Liao, En‐Ying Wang, Ying‐Shuo Hsu, Ming‐Shao Tsai, Cheng‐Jung Wu, Chia‐Hao Chang, Yi‐Li Hwang, Han‐Lo Teng, Jun‐Wei Hsieh, Chien‐Yu Huang   +9 more
wiley   +1 more source

Evaluation of sixteen antimotion sickness drugs under controlled laboratory conditions [PDF]

Evaluation of antimotion sickness drugs under controlled laboratory ...
Graybiel, A., Wood, C. D.
core   +1 more source